Drug profile · INN
influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)
PANDEMRIX
influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted) (PANDEMRIX) is a biological vaccine - induces immune response.
EMA: unknown Antiinfectives for systemic use (J07) J07BB02
Patents linked 0
Pipeline programs 59
News articles 0
Drug details — influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 59
- Data quality
- 0.83
Quick answer
influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted) (PANDEMRIX) is a biological vaccine - induces immune response.
Key facts
INN influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)
Brand PANDEMRIX
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB02
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Pipeline programs
- Baloxavir Marboxil
- FluLaval® Quadrivalent
- GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
- H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)
- Influenza A (H5N1) Virus monovalent vaccine
- Influenza Virus Vaccine
- Influenza vaccine
- Influenza vaccine GSK1562902A Formulation 1
Related & competitor drugs
Frequently asked questions
What is influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)?
influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted) (PANDEMRIX) is a biological vaccine - induces immune response.
What is the brand name for influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)?
PANDEMRIX is a marketed brand name for influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.